Province: Zhejiang
Industry: Healthcare
Venus Medtech, established in 2009 and based in the Hangzhou National High-Tech Industrial Development Zone (Binjiang), specializes in the development and industrialization of transcatheter therapy products for structural heart diseases. The company was listed on the main board of the Hong Kong Stock Exchange (SEHK) in 2019. In 2021, Venus Medtech donated ¥57.5 million ($8.91 million) to Chongqing Da Ai Yu Shang Charity Foundation for poverty alleviation purposes.